首页> 外文期刊>Journal of Clinical and Diagnostic Research >Pathological and Biochemical Evaluation of Toxic Effects of Repeated Administration of Jasada Bhasma (Zinc Ash Formulation) in Wistar Albino Rats
【24h】

Pathological and Biochemical Evaluation of Toxic Effects of Repeated Administration of Jasada Bhasma (Zinc Ash Formulation) in Wistar Albino Rats

机译:Wistar白化病大鼠反复服用Jasada Bhasma(锌粉配方)的毒性的病理学和生化评估

获取原文
           

摘要

Introduction: Jasada Bhasma is the well known potent zinc formulation commonly used in ?Ayurveda? medicine system. Its extensive usage in the health care sector is proved to be successful in the treatment of certain illness and is considered to be popular in its stability, lower dose, and its availability.Aim: To evaluate the toxicity profile of Jasada Bhasma with primary emphasis on haematological, biochemical and histopathological changes in Wistar albino rats.Materials and Methods: For toxicity study, Wistar albino rats of either sex, weighing from 150-225 gm of body weight were used, and they were divided into three groups, ten rats in each group. Group-I administered with carboxymethyl cellulose and considered as vehicle control. Group-II and III were administered with two levels of Jasada Bhasma, i.e., 10.8 mg/kg (Therapeutic dose) and 54 mg/kg (Five times of therapeutic dose) respectively for 28 consecutive days. On the 28th day, the animals were sacrificed. Blood sample and vital organs were collected for haematological, biochemical and histopathological examinations.Results: The repeated administration of Jasada Bhasma on Wistar albino rats did not produce remarkable toxicity changes at both the dose levels in most of the haematological parameters tested except there was a significant (pConclusion: The repeated administration of test drug Jasada Bhasma at therapeutic dose was relatively safer; however, at higher dose level it produces some functional changes in histopathological sections of kidney and liver.
机译:简介:Jasada Bhasma是“阿育吠陀”中常用的有效锌制剂。医学系统。它在医疗保健领域的广泛使用已被证明可成功治疗某些疾病,并被认为在其稳定性,较低剂量和可获得性方面广受欢迎。目的:评估Jasada Bhasma的毒性特征,重点是材料与方法:为研究毒性,使用体重在150-225 gm的两性Wistar白化病大鼠,分为三组,每组十只。组。 -I组与羧甲基纤维素一起施用,并被认为是媒介物对照。第II组和第III组连续28天分别服用两种水平的Jasada Bhasma,即分别为10.8 mg / kg(治疗剂量)和54 mg / kg(治疗剂量的五倍)。在第28天,处死动物。结果:在Wistar白化病大鼠上重复施用Jasada Bhasma并没有在两个剂量水平上对所测试的大多数血液学参数产生明显的毒性变化,只是存在显着的血液学和血液学检查(p结论:以治疗剂量重复施用测试药物Jasada Bhasma相对安全;但是,在更高剂量水平下,它会在肾脏和肝脏的组织病理学切片中产生某些功能变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号